The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales

Enregistré dans:
Détails bibliographiques
Publié dans:Rheumatology (Oxford)
Auteurs principaux: McCarthy, Eoghan M., Sutton, Emily, Nesbit, Stephanie, Parker, Ben, Jayne, David, Griffiths, Bridget, Isenberg, David A., Rahman, Anisur, Gordon, Caroline, D’Cruz, David P., Rhodes, Benjamin, Lanyon, Peter, Vital, Edward M., Yee, Chee-Seng, Edwards, Christopher J., Teh, Lee-Suan, Akil, Mohammed, McHugh, Neil J., Zoma, Asad, Bruce, Ian N.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Letters to the Editor
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850864/
https://ncbi.nlm.nih.gov/pubmed/28431104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex044
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires